Bio-Connect
Human Oxidized LDL ELISA

Human Oxidized LDL ELISA

CE-IVD
10-1143-01
Mercodia
Product group Assays
Price on request
96 wells
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Mercodia
  • Product Name
    Human Oxidized LDL ELISA
  • Delivery Days Customer
    7
  • Applications
    ELISA
  • Assay Detection Range
    1.4 - 19.0 mU/L (9 - 125 U/L when multiplied with dilution factor)
  • Certification
    CE-IVD
  • Scientific Description
    Mercodia Oxidized LDL ELISA kit is intended to be used for in vitro quantification of oxidized low-density lipoproteins (oxidized LDL) in human serum or plasma. Mercodia Oxidized LDL ELISA is a unique sandwich ELISA based on the proprietary mouse monoclonal antibody 4E6, which is directed against a conformational epitope in oxidized ApoB-100. Elevated plasma levels of oxidized LDL are associated with higher cardiovascular risk and higher incidence of metabolic diseases. • CE/IVD labeled on selected markets. • Controls included in the kit. • Accurately measures the physiological signaling on scavenging macrophages that generates foam cells, vascular inflammation, and atherosclerosis.
  • UNSPSC
    41116133

References

  • Spoto, B. et al. Oxidized LDL, Gamma-Glutamyltransferase and Adverse Outcomes in Older Adults. J. Am. Geriatr. Soc. 65, e77–e82 (2017).
    Read more
  • Kaikkonen JE, Kresanov P, Ahotupa M, et al. High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation: the Cardiovascular Risk in Young Finns Study. Free Radic Res. 2014;48(4):420-6.
    Read more
  • Lerman RH, Desai A, Lamb JJ, Chang JL, Darland G, Konda VR. A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals. Glob Adv Health Med. 2014;3(2):34-9.
    Read more
  • Verhoeven V, Van der auwera A, Van gaal L, et al. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015;15:52.
    Read more